ArticleJournal of hepatocellular carcinoma2026
GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway.
Jiaqian He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.